| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥2993.3B | ¥3086.2B | -3.0% |
| Operating Income | ¥151.8B | ¥152.0B | -0.1% |
| Profit Before Tax | ¥190.9B | ¥191.7B | -0.4% |
| Net Income | ¥148.7B | ¥148.4B | +0.2% |
| ROE | 3.7% | 3.8% | - |
FY2026 Q3 cumulative results show revenue of 299.3B yen (YoY -3.0%), operating income of 15.2B yen (YoY -0.1%), ordinary income of 19.1B yen, and net income attributable to owners of 14.4B yen (YoY +0.2%). The company maintained near-flat profitability despite top-line contraction, supported by improved spreads from raw material price declines and increased sales volumes in Super Absorbent Polymer (SAP) and electronics materials. However, elevated selling, general and administrative expenses, decreased inventory valuation gains, and impairment losses at equity-method affiliates partially offset these gains. Operating cash flow of 40.3B yen significantly exceeded net income, demonstrating strong cash conversion at 2.81x, though working capital deterioration and elevated shareholder returns relative to free cash flow raise sustainability concerns.
Revenue declined 3.0% YoY to 299.3B yen, driven by lower sales in specialty esters and other (EO derivatives) segments despite 20.0% growth in electronics materials and volume increases in SAP. Gross profit margin compressed to 19.0% from prior levels as inventory valuation gains decreased, though raw material cost declines provided partial offset. Operating income remained essentially flat at 15.2B yen (-0.1% YoY) as spread improvements and volume gains were negated by increased SG&A expenses (42.9B yen, representing 14.3% of revenue), primarily from higher logistics costs accompanying SAP volume growth, increased R&D spending, and consolidation of Etec subsidiary.
The gap between operating income (15.2B yen) and ordinary income (19.1B yen) reflects 3.9B yen in net non-operating income, while the further expansion to net income (14.4B yen) involves income tax expenses of 4.2B yen. Equity-method investment losses deteriorated due to MMA (methyl methacrylate) market downturn and associated impairment charges at affiliates, representing a non-recurring negative factor. The company follows a revenue down/profit flat pattern, where operational efficiency gains and favorable input costs offset volume declines to preserve profitability.
Acrylic Acid/SAP segment is the core business, generating revenue of 162.6B yen (-2.9% YoY) and segment profit of 8.5B yen (+16.1% YoY), representing approximately 54% of total revenue and 51% of segment profit. This segment drove overall profit performance through SAP volume expansion in emerging markets and significant spread improvement from declining propylene prices.
Electronics segment achieved the strongest profit growth with revenue of 18.5B yen (+20.0% YoY) and segment profit of 3.9B yen (+60.1% YoY), driven by successful expansion of display-related materials in the Chinese market and improved product mix toward higher value-added offerings. Operating margin in this segment substantially exceeds the company average.
EO Derivatives/Other segment posted revenue of 45.9B yen (-15.8% YoY) and segment profit of 2.4B yen (-56.6% YoY), experiencing the sharpest profit decline due to weak specialty ester demand and competitive pressure from low-priced Chinese imports in overseas markets.
Specialty segment recorded revenue of 36.3B yen (-5.5% YoY) and segment profit of 3.9B yen (-0.7% YoY), with surfactants maintaining relatively stable margins through spread expansion despite volume headwinds.
Solutions segment (construction, energy, environmental catalysts) posted revenue of 36.1B yen (+9.8% YoY) but segment loss of 2.6B yen, as consolidation of Etec subsidiary increased volumes but added R&D and integration costs that overwhelmed profit contribution.
Profitability: ROE of 3.6% (prior year reference point unavailable in data), operating margin of 5.1%, and net profit margin of 4.8% indicate subdued profitability levels. ROIC of 2.6% reflects low returns on invested capital, signaling capital efficiency challenges.
Cash Quality: Operating cash flow to net income ratio of 2.81x demonstrates strong cash-backed earnings quality. Free cash flow of 9.5B yen was generated after capital expenditure of 32.5B yen.
Investment: CapEx to depreciation ratio of 1.02x (32.5B yen CapEx vs. 31.9B yen depreciation) indicates a growth investment phase, primarily directed toward SAP capacity expansion and electronics materials facilities.
Financial Health: Equity ratio of 68.7% and current ratio data indicates robust balance sheet strength with conservative capitalization. Total assets of 564.7B yen increased 3.9% from 543.7B yen as capital investments and acquisition of Etec expanded the asset base.
Efficiency: Asset turnover ratio of 0.530 reflects prolonged working capital cycles, with days sales outstanding at 118 days, days inventory outstanding at 133 days, and cash conversion cycle at 161 days representing areas requiring improvement.
Operating CF of 40.3B yen represents 2.81x net income of 14.4B yen, indicating earnings quality is strong and profits are well-supported by cash generation. The primary drivers include depreciation and amortization add-backs of 31.9B yen, though partially offset by working capital increases in receivables and inventory.
Investing CF of -30.9B yen primarily reflects capital expenditures of 32.5B yen directed toward SAP production capacity expansion and electronics materials facilities, consistent with the company's growth strategy in these segments. The consolidation of Etec subsidiary also contributed to investing outflows.
Financing CF of -14.8B yen includes dividend payments of 16.5B yen and share buybacks of 7.0B yen, partially offset by net borrowing increases. The long-term debt increase of 16.2B yen (+89.0% YoY) funds growth investments and M&A activities.
FCF of 9.5B yen (Operating CF 40.3B yen minus CapEx 32.5B yen) is positive but insufficient to cover total shareholder returns of 23.5B yen (dividends 16.5B yen plus buybacks 7.0B yen), resulting in FCF coverage ratio of 0.40x for total distributions. This gap between cash generation and capital allocation necessitates external funding or reserve drawdown.
Cash generation assessment: Adequate. While operating cash flow is robust and earnings quality strong, the sustainability of elevated shareholder returns relative to free cash flow warrants monitoring, particularly if capital investment requirements remain elevated.
Ordinary income of 19.1B yen versus net income of 14.4B yen shows a 24.6% gap, primarily attributable to income tax expenses of 4.2B yen (effective tax rate of approximately 22%). Non-operating income of 3.9B yen (net) bridges operating income to ordinary income, with foreign exchange gains and interest income as typical components.
Non-recurring items impacting the period include impairment losses recognized at equity-method affiliates due to MMA market deterioration, representing a one-time negative factor. Additionally, the decrease in inventory valuation gains compared to prior year (-6.5B yen impact on segment profit) reflects market normalization rather than sustainable operational deterioration.
Accruals assessment: Operating CF significantly exceeds net income (2.81x ratio), indicating negative accruals of -4.6% relative to total assets. This pattern suggests conservative accounting and high earnings quality, though the prolonged working capital cycle (DSO 118 days, DIO 133 days) indicates operational efficiency challenges that could constrain future cash generation if not addressed.
Full-year guidance (unchanged from November 7 revision) projects revenue of 405.0B yen, operating income of 18.0B yen, segment profit of 19.7B yen, and net income of 15.0B yen. Q3 cumulative progress rates are: revenue 73.9%, operating income 84.3%, and net income 99.1%.
Operating income progress of 84.3% exceeds the standard 75% benchmark for Q3, suggesting conservative full-year guidance or expectation of Q4 headwinds. Net income progress at 99.1% indicates near-complete achievement of the annual target, implying minimal additional contribution expected in Q4. This variance suggests either extraordinary gains recognized through Q3 or potential downside risk to full-year net income guidance.
The company maintained its November revision unchanged, implying management confidence in Q4 recovery to offset Q3 weakness in specialty esters and equity-method losses. Key assumptions include naphtha price of 62,900 yen/kL, USD/JPY at 147 yen, and EUR/JPY at 171 yen for the full year. Achievement depends on sustained electronics materials demand and SAP volume growth, while risks center on prolonged weakness in specialty esters and MMA market recovery timing.
Dividends paid during the nine-month period totaled 16.5B yen (interim dividend of 54 yen per share based on 1.5B shares outstanding). Full-year dividend guidance of 50 yen per share appears inconsistent with the interim payment of 54 yen, suggesting either special dividend components or reconciliation needed in reported figures.
The calculated payout ratio of 119.0% based on interim dividends and nine-month net income substantially exceeds sustainable levels. Share buybacks of 7.0B yen during the period bring total shareholder returns to 23.5B yen, representing a total return ratio of 163% relative to nine-month net income.
Free cash flow of 9.5B yen covers only 40% of total distributions, indicating the current capital allocation policy relies on balance sheet capacity rather than internally generated cash. With equity ratio of 68.7% and net cash position (cash 50.7B yen exceeds interest-bearing debt 52.9B yen on net basis), near-term dividend sustainability is supported by balance sheet strength. However, if capital investment requirements remain elevated and ROIC does not improve from current 2.6%, the company will likely need to moderate distribution levels or enhance operational cash generation to maintain sustainable capital allocation.
Near-term: Q4 performance recovery to achieve full-year guidance targets, particularly in SAP and electronics materials segments; stabilization of MMA market and equity-method affiliate performance; progress on working capital reduction initiatives targeting DSO and DIO compression; completion of SAP capacity expansion projects.
Long-term: Penetration of high-value electronics materials in China market for display applications; development and commercialization of battery materials (LiB electrolyte, ammonia decomposition catalysts); expansion of construction solutions business through Etec integration synergies; ROIC improvement toward industry median levels through operational efficiency gains and capital allocation optimization; potential for shareholder return policy revision to align with sustainable free cash flow generation capability.
Industry Position (Reference - Proprietary Analysis)
Profitability: Net profit margin of 4.8% falls below the manufacturing industry median of 6.3% (IQR: 3.2%-9.0%), placing the company in the lower half of peer performance. Operating margin of 5.1% significantly underperforms the industry median of 8.3% (IQR: 4.8%-12.6%). ROE of 3.6% trails the industry median of 5.0% (IQR: 2.9%-8.1%), while ROIC of 2.6% also lags the median of 5.0% (IQR: 3.0%-10.0%).
Financial Health: Equity ratio of 68.7% exceeds the industry median of 63.8% (IQR: 49.5%-74.7%), indicating above-average financial stability and conservative capital structure. Current ratio data suggests adequate liquidity positioning within industry norms.
Efficiency: Asset turnover of 0.530 underperforms the industry median of 0.58 (IQR: 0.42-0.66). Receivables turnover at 118 days substantially exceeds the industry median of 83 days (IQR: 68-115 days), signaling collection efficiency challenges. Inventory turnover at 133 days also exceeds the industry median of 109 days (IQR: 50-155 days), indicating higher working capital intensity than peers. Operating working capital cycle of 161 days extends well beyond the industry median of 108 days (IQR: 72-143 days).
Growth: Revenue decline of 3.0% underperforms the industry median growth of 2.7% (IQR: -1.9% to +7.9%). CapEx to D&A ratio of 1.02x falls below the industry median of 1.44x (IQR: 1.19-1.76), suggesting relatively modest growth investment intensity compared to peers.
Industry: Manufacturing sector (98 companies), Comparison: FY2025 Q3 data, Source: Proprietary analysis
Working Capital Deterioration: Days sales outstanding of 118 days and days inventory outstanding of 133 days result in a cash conversion cycle of 161 days, substantially exceeding industry median of 108 days. This extended cycle ties up approximately 13.2B yen in excess working capital compared to industry-standard efficiency, constraining liquidity and return on invested capital. Further deterioration would pressure both cash generation and financial flexibility.
Unsustainable Capital Allocation: Total shareholder returns of 23.5B yen (163% of net income) exceed free cash flow of 9.5B yen by 2.5x, creating a 14.0B yen annual funding gap. While the current equity ratio of 68.7% provides near-term buffer, continuation of this policy would deplete retained earnings by approximately 70B yen over five years, eventually constraining dividend capacity or necessitating distribution cuts if operational cash generation does not improve substantially.
Specialty Chemicals Market Exposure: Weak demand in specialty esters and sustained MMA market downturn drove segment profit decline of 56.6% in EO derivatives and impairment charges at equity-method affiliates. These segments represent approximately 15% of revenue, and prolonged market weakness or intensified competition from low-cost Chinese manufacturers could result in additional asset impairments estimated at 5-10B yen and sustained margin compression of 2-3 percentage points in affected segments.
Strong cash-backed earnings quality evidenced by operating cash flow of 2.81x net income demonstrates the company's ability to convert accounting profits into cash, a positive fundamental characteristic. However, this cash generation is being constrained by working capital inefficiency, with the 161-day cash conversion cycle indicating approximately 13.2B yen in excess capital tied up in receivables and inventory compared to industry-standard efficiency levels. Resolution of working capital management would unlock substantial cash flow capacity and improve ROIC from current below-industry 2.6% toward peer median levels.
Strategic portfolio rebalancing is progressing with electronics materials segment achieving 60.1% profit growth through successful China market penetration and product mix improvement toward higher value-added offerings. This segment now contributes 23% of segment profit despite representing only 6% of revenue, indicating substantially superior margins and return characteristics compared to mature chemical segments. Continued shift toward electronics, battery materials, and specialty applications represents a multi-year earnings quality improvement opportunity.
Capital allocation policy sustainability requires reassessment, as the current 163% total return ratio substantially exceeds free cash flow generation capacity. While balance sheet strength with 68.7% equity ratio provides near-term capacity to support elevated distributions, the combination of elevated capital investment requirements (32.5B yen annually for growth projects) and below-industry ROIC suggests returns to shareholders should be moderated to sustainable levels aligned with 40-50% of free cash flow pending operational efficiency improvements. The 14.0B yen annual funding gap between distributions and FCF is unsustainable over the medium term without either ROIC improvement or policy adjustment.
This report was automatically generated by AI integrating XBRL earnings data and PDF presentation materials as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.
AI analysis of PDF earnings presentation
Nippon Shokubai Co., Ltd.’s Q3 FY2026 (fiscal year ending March 2026) results were revenue of 2,993億円 (▲93億円, ▲3.0%), operating profit of 152億円 (▲0億円, ▲0.1%), and segment profit of 167億円 (▲16億円, ▲8.7%), resulting in lower revenue and earnings overall, while quarterly profit increased to 144億円 (+3億円, +2.5%). Higher sales volumes of electronics materials and SAP, together with spread expansion driven by lower raw material prices, contributed positively; however, higher SG&A, a decrease in inventory valuation gains, and impairment losses at equity-method affiliates weighed on profits. The Solutions business achieved higher revenue and profit. Full-year guidance (revised on 11/7) remains unchanged at revenue of 4,050億円, operating profit of 180億円, segment profit of 197億円, and net profit of 150億円.
SAP (superabsorbent polymers): volumes increased due to expansion in emerging markets; spread widened on lower raw material prices, improving profitability. Electronics: significant profit growth (+60.1%) driven by expanded sales of display-related materials to the China market and a favorable product mix. Materials business: profit declined (▲14.9%) due to a decrease in inventory valuation gains, higher SG&A, and deterioration in equity-method gains/losses (MMA market downturn). Solutions business: despite higher R&D expenses and costs associated with making E-TEC a subsidiary, profit increased (+9.6%) on spread expansion and higher volumes. Full-year guidance maintained unchanged from the November revision, with a recovery expected in Q4.
For the full year, the company forecasts revenue of 4,050億円 (▲43億円), operating profit of 180億円 (▲11億円), segment profit of 197億円 (▲34億円), and net profit of 150億円 (▲24億円). Assumptions: naphtha price 62,900円/kL; FX 147円/ドル and 171円/ユーロ. Q4 is expected to recover from progress through Q3. Demand for Electronics and SAP is expected to remain solid, while a prolonged slump in specialty esters and MMA market conditions remains a risk.
While cumulative Q3 posted lower revenue and earnings, improved spreads driven by lower raw material prices and increased sales volumes provided support. Management recognizes that higher SG&A, a decline in inventory valuation gains, and impairment at equity-method affiliates pressured profits. Achieving full-year guidance requires profit improvement in Q4. The company will continue to focus on growth areas such as electronics materials and SAP, and plans capital allocation of 550億円 in capital expenditures, 325億円 in depreciation, and 171億円 in R&D expenses.
Strengthen expansion in emerging markets for the SAP business and invest in capacity increases (334億円 in capital expenditures underway). Expand sales of electronics materials (display-related) to the China market and shift the product mix toward higher value-added offerings. Expand the scope of the Solutions business (construction field) by making E-TEC a subsidiary. Strengthen R&D investment in growth areas such as environmental catalysts and battery materials (LIB electrolytes, ammonia decomposition catalysts). Promote working capital management to improve capital efficiency (optimize inventories and accounts receivable).
Weak demand for specialty esters and low-priced competition from Chinese products causing volume declines and spread compression. Deterioration in equity-method gains/losses due to a decline in MMA (methyl methacrylate) market conditions. Pressure on conversion margin profits due to a decrease in inventory valuation gains. Increase in SG&A (higher logistics costs due to increased SAP volumes, higher R&D expenses, and impacts from making E-TEC a subsidiary). Risk of continued weakness in overseas markets (AES, specialty esters).